{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:25:51Z","timestamp":1768537551975,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1186\/s12913-015-1098-3","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T12:36:29Z","timestamp":1443616589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Costs of HIV\/AIDS treatment in Indonesia by time of treatment and stage of disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Adiatma Y. M.","family":"Siregar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dindin","family":"Komarudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi","family":"Wisaksana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinout","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"van der Ven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Baltussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"1098_CR1","unstructured":"Directorate General CDC & EH - Ministry of Health (MoH) of Indonesia: Laporan Perkembangan HIV-AIDS Triwulan IV Tahun 2014. Jakarta, Indonesia; 2014."},{"key":"1098_CR2","volume-title":"Republic of Indonesia Country report on the Follow up to the Declaration of Commitment on HIV\/AIDS (UNGASS), Reporting Period 2010\u20132011","author":"National AIDS Commission (NAC)","year":"2012","unstructured":"National AIDS Commission (NAC). Republic of Indonesia Country report on the Follow up to the Declaration of Commitment on HIV\/AIDS (UNGASS), Reporting Period 2010\u20132011. 2012."},{"key":"1098_CR3","volume-title":"Mathematic model of HIV epidemic in Indonesia","author":"Ministry of Health of Indonesia","year":"2008","unstructured":"Ministry of Health of Indonesia. Mathematic model of HIV epidemic in Indonesia. 2008."},{"key":"1098_CR4","volume-title":"Global HIV\/AIDS response: epidemic update and health sector progress towards universal access","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Global HIV\/AIDS response: epidemic update and health sector progress towards universal access. 2011."},{"key":"1098_CR5","volume-title":"National guideline on clinical procedures on HIV infection and antiretroviral therapy on adults","author":"Ministry of Health of the Republic of Indonesia - Directorate General of Communicable Disease Control and Environment Health","year":"2011","unstructured":"Ministry of Health of the Republic of Indonesia - Directorate General of Communicable Disease Control and Environment Health. National guideline on clinical procedures on HIV infection and antiretroviral therapy on adults. Jakarta, Indonesia: Ministry of Health of the Republic of Indonesia; 2011."},{"key":"1098_CR6","unstructured":"Ministry of Health of the Republic of Indonesia: Minisitry of Health of the Republic of Indonesia Regulation Number 21 Year 2013 on Response to HIV and AIDS. Jakarta, Indonesia; 2013:1\u201331"},{"key":"1098_CR7","unstructured":"Ministry of Health of the Republic of Indonesia: Minisitry of Health of the Republic of Indonesia Regulation Number 87 Year 2014 on Guideline for Antiretroviral Treatment. Jakarta, Indonesia; 2014:1\u2013121"},{"key":"1098_CR8","first-page":"e108304","volume":"In Press","author":"E Tagar","year":"2013","unstructured":"Tagar E, Sundaram M, Condliffe K, Over M, Matatiyo B, Chimbwandira F, et al. Multi-country analysis of treatment costs for HIV\/AIDS (MATCH): unit costing at 161 representative facilities in ethiopia, Malawi, Rwanda, South Africa and Zambia. PLoS Med. 2013;In Press:e108304.","journal-title":"PLoS Med"},{"key":"1098_CR9","doi-asserted-by":"crossref","unstructured":"Eaton JW, Menzies N a., Stover J, Cambiano V, Chindelevitch L, Cori A, et al.: Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models. Lancet Glob Heal 2014, 2.","DOI":"10.1016\/S2214-109X(13)70172-4"},{"key":"1098_CR10","doi-asserted-by":"publisher","first-page":"e1001055","DOI":"10.1371\/journal.pmed.1001055","volume":"8","author":"L Long","year":"2011","unstructured":"Long L, Brennan A, Fox MP, Ndibongo B, Jaffray I, Sanne I, et al. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. PLoS Med. 2011;8:e1001055.","journal-title":"PLoS Med"},{"key":"1098_CR11","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/j.1365-3156.2011.02870.x","volume":"16","author":"HPW Oudenhoven","year":"2011","unstructured":"Oudenhoven HPW, Meijerink H, Wisaksana R, Oetojo S, Indrati A, van der Ven AJ a M, et al. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting. Trop Med Int Heal. 2011;16:1372\u20139.","journal-title":"Trop Med Int Heal"},{"key":"1098_CR12","first-page":"4","volume":"00","author":"M Jong De","year":"2012","unstructured":"De Jong M, Wisaksana R, Meijerink H, Indrati A, Vande Ven AJM, Alisjahbana B, et al. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study. Trop Med Int Heal. 2012;00:4\u20136.","journal-title":"Trop Med Int Heal"},{"issue":"Suppl 1","key":"1098_CR13","first-page":"28","volume":"41","author":"AR Indrati","year":"2009","unstructured":"Indrati AR, van Crevel R, Parwati I, Tjandrawati A, Noormartany, Kurmalawati J. Screening and diagnosis of HIV-infection in Indonesia: one, two or three tests? Acta Med Indones. 2009;41 Suppl 1:28\u201332.","journal-title":"Acta Med Indones"},{"key":"1098_CR14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1126\/science.1121176","volume":"311","author":"J Stover","year":"2006","unstructured":"Stover J, Bertozzi S, Gutierrez J-P, Walker N, Stanecki K a, Greener R, et al. The global impact of scaling up HIV\/AIDS prevention programs in low- and middle-income countries. Science. 2006;311:1474\u20136.","journal-title":"Science"},{"key":"1098_CR15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1365-3156.2008.02091.x","volume":"13","author":"M Posse","year":"2008","unstructured":"Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Heal. 2008;13:904\u201313.","journal-title":"Trop Med Int Heal"},{"key":"1098_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/heapol\/czq004","volume":"25","author":"S Riyarto","year":"2010","unstructured":"Riyarto S, Hidayat B, Johns B, Probandari A, Mahendradhata Y, Utarini A, et al. The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia. Health Policy Plan. 2010;25:272\u201382.","journal-title":"Health Policy Plan"},{"key":"1098_CR17","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2005","unstructured":"Drummond MF, Sculpher MJ, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press; 2005."},{"key":"1098_CR18","volume-title":"Circular Letter No. SE-03\/PB\/2007 on the Main Salary Adjustment for Government Official, Judge of General, State Administrative, and Religious Courts, National Army, and National Police","author":"Ministry of Finance (MoF) of Indonesia","year":"2007","unstructured":"Ministry of Finance (MoF) of Indonesia. Circular Letter No. SE-03\/PB\/2007 on the Main Salary Adjustment for Government Official, Judge of General, State Administrative, and Religious Courts, National Army, and National Police. 2007."},{"key":"1098_CR19","first-page":"1","volume":"10","author":"T Adam","year":"2003","unstructured":"Adam T, Evans DB, Murray CJL. Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc. 2003;10:1\u201310.","journal-title":"Cost Eff Resour Alloc"},{"key":"1098_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1086\/649884","volume":"50","author":"MA Bender","year":"2010","unstructured":"Bender MA, Kumarasamy N, Mayer KH, Wang B, Walensky RP, Flanigan T, et al. Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50:416\u201325.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1098_CR21","unstructured":"The World Bank: Official Exchange Rate (LCU per US$, period average) 2010. accessed 2011, http:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF ."},{"key":"1098_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1258\/095646206780071081","volume":"17","author":"NI Paton","year":"2006","unstructured":"Paton NI, Chapman CAT, Sangeetha S, Mandalia S, Bellamy R, Beck EJ. Cost and cost-effectiveness of antiretroviral therapy for HIV infection in Singapore. Int J STD AIDS. 2006;17:699\u2013705.","journal-title":"Int J STD AIDS"},{"key":"1098_CR23","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1097\/00002030-200311070-00013","volume":"17","author":"T Kitajima","year":"2003","unstructured":"Kitajima T, Kobayashi Y, Chaipah W, Sato H, Chadbunchachai W, Thuennadee R. Costs of medical services for patients with HIV\/AIDS in Khon Kaen, Thailand. AIDS. 2003;17:2375\u201381.","journal-title":"AIDS"},{"key":"1098_CR24","doi-asserted-by":"publisher","first-page":"e1000189","DOI":"10.1371\/journal.pmed.1000189","volume":"6","author":"R Leisegang","year":"2009","unstructured":"Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, et al. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med. 2009;6:e1000189.","journal-title":"PLoS Med"},{"key":"1098_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.7326\/0003-4819-111-3-223","volume":"111","author":"H Masur","year":"1989","unstructured":"Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989;111:223\u201331.","journal-title":"Ann Intern Med"},{"key":"1098_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM199001183220304","volume":"322","author":"J Phair","year":"1990","unstructured":"Phair J, Mu\u00f1oz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990;322:161\u20135.","journal-title":"N Engl J Med"},{"key":"1098_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","volume":"130","author":"V Miller","year":"1999","unstructured":"Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, Katzenstein T, et al. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med. 1999;130:570\u20137.","journal-title":"Ann Intern Med"},{"key":"1098_CR28","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJM200005113421907","volume":"342","author":"JA Kovacs","year":"2000","unstructured":"Kovacs JA, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med. 2000;342:1416\u201329.","journal-title":"N Engl J Med"},{"key":"1098_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2009","unstructured":"Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48\u201357.","journal-title":"Lancet"},{"key":"1098_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-6405-7-3","volume":"7","author":"KA Johansson","year":"2010","unstructured":"Johansson KA, Robberstad B, Norheim OF. Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS Res Ther. 2010;7:3.","journal-title":"AIDS Res Ther"},{"key":"1098_CR31","unstructured":"NIAID START Trial Confirms that Immediate Treatment of HIV with Antiretroviral Drugs (ARVs) Protects the Health of People Living with HIV [ http:\/\/www.who.int\/hiv\/mediacentre\/news\/niaid_start\/en\/ #]. Accessed date 7 September 2015"},{"key":"1098_CR32","volume-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, June 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, June 2013. Geneva: World Health Organization; 2013."},{"key":"1098_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","volume":"375","author":"P Mugyenyi","year":"2010","unstructured":"Mugyenyi P, Walker AS, Hakim J, Munderi P, Gibb DM, Kityo C, et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet. 2010;375:123\u201331.","journal-title":"Lancet"},{"key":"1098_CR34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00126334-200212010-00002","volume":"31","author":"N Kumarasamy","year":"2002","unstructured":"Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CCJ, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002;31:378\u201383.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1098_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-6405-9-21","volume":"9","author":"Y a Wondimeneh","year":"2012","unstructured":"Wondimeneh Y a, Ferede GE, Yismaw GW, Muluye DF. Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, North West Ethiopia. AIDS Res Ther. 2012;9:21.","journal-title":"AIDS Res Ther"},{"key":"1098_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/0300-1652.137187","volume":"55","author":"A Abdollahi","year":"2014","unstructured":"Abdollahi A, Saffar H, Shoar S, Jafari S. Is total lymphocyte count a predictor for CD4 cell count in initiation antiretroviral therapy in HIV-infected patients? Niger Med J. 2014;55:289.","journal-title":"Niger Med J"},{"key":"1098_CR37","doi-asserted-by":"publisher","first-page":"e69704","DOI":"10.1371\/journal.pone.0069704","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen J, Li W, Huang X, Guo C, Zou R, Yang Q, et al. Evaluating Total Lymphocyte Count as a Surrogate Marker for CD4 Cell Count in the Management of HIV-Infected Patients in Resource-Limited Settings: A Study from China. PLoS One. 2013;8:e69704.","journal-title":"PLoS One"},{"key":"1098_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/0975-9727.146418","volume":"6","author":"S Jain","year":"2015","unstructured":"Jain S, Singh A, Singh R, Bajaj J, Damle A. Evaluation of total lymphocyte count (TLC) as a surrogate marker for CD4 count in HIV-positive patients for resource-limited settings. Muller J Med Sci Res. 2015;6:23.","journal-title":"Muller J Med Sci Res"},{"key":"1098_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2334-12-128","volume":"12","author":"C Obirikorang","year":"2012","unstructured":"Obirikorang C, Quaye L, Acheampong I. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings. BMC Infect Dis. 2012;12:128.","journal-title":"BMC Infect Dis"},{"key":"1098_CR40","first-page":"29","volume":"27","author":"MY Daud","year":"2015","unstructured":"Daud MY, Qazi RA, Bashir N. Total lymphocyte count as a susbtitute to CD4 count in management of HIV infected individuals in resource lmited society. J Ayub Med Coll. 2015;27:29\u201331.","journal-title":"J Ayub Med Coll"},{"key":"1098_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2231-0770.127413","volume":"4","author":"SS Karanth","year":"2014","unstructured":"Karanth SS, Rau NR, Gupta A, Kamath A, Shanbhogue V, Pruthvi BC. Utility of total lymphocyte count as a surrogate for absolute CD4 count in the adult Indian HIV population: A prospective study. Avicenna J Med. 2014;4:1\u20134.","journal-title":"Avicenna J Med"},{"issue":"Suppl 1","key":"1098_CR42","first-page":"75","volume":"41","author":"I Afriandi","year":"2009","unstructured":"Afriandi I, Aditama TY, Mustikawati D, Oktavia M, Alisjahbana B, Riono P. HIV and injecting drug use in Indonesia: epidemiology and national response. Acta Med Indones. 2009;41 Suppl 1:75\u20138.","journal-title":"Acta Med Indones"},{"key":"1098_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493\u2013505.","journal-title":"N Engl J Med"},{"key":"1098_CR44","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014\u201328.","journal-title":"Lancet"},{"key":"1098_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(08)61732-8","volume":"373","author":"KM Cock De","year":"2009","unstructured":"De Cock KM, Gilks CF, Lo Y-R, Guerma T. Can antiretroviral therapy eliminate HIV transmission? Lancet. 2009;373:7\u20139.","journal-title":"Lancet"},{"key":"1098_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-3156.2010.02675.x","volume":"16","author":"AYM Siregar","year":"2011","unstructured":"Siregar AYM, Komarudin D, Wisaksana R, van Crevel R, Baltussen R. Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia. Trop Med Int Heal. 2011;16:193\u20139.","journal-title":"Trop Med Int Heal"},{"key":"1098_CR47","doi-asserted-by":"crossref","unstructured":"Portelli MS, Tenni B, Kounnavong S, Chanthivilay P: Barriers to and Facilitators of Adherence to Antiretroviral Therapy Among People Living With HIV in Lao PDR: A Qualitative Study. Asia Pac J Public Health 2012, 53.","DOI":"10.1177\/1010539512442082"},{"key":"1098_CR48","doi-asserted-by":"publisher","first-page":"e5790","DOI":"10.1371\/journal.pone.0005790","volume":"4","author":"MWG Brinkhof","year":"2009","unstructured":"Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4:e5790.","journal-title":"PLoS One"},{"key":"1098_CR49","volume-title":"Lost to follow up from ARV treatment: reasons and true outcome of patients in Bandung, Indonesia","author":"H Haroen","year":"2011","unstructured":"Haroen H, Handayani M, Puspitasari TS, Pinxten L, Van Den Bome B, Halfens R. Lost to follow up from ARV treatment: reasons and true outcome of patients in Bandung, Indonesia. Indones: One Results IMPACT Progr Bandung; 2011."},{"issue":"Suppl 1","key":"1098_CR50","first-page":"45","volume":"41","author":"R Wisaksana","year":"2009","unstructured":"Wisaksana R, Alisjahbana B, van Crevel R, Kesumah N, Sudjana P, Sumantri R. Challenges in delivering HIV-care in Indonesia: experience from a referral hospital. Acta Med Indones. 2009;41 Suppl 1:45\u201351.","journal-title":"Acta Med Indones"},{"key":"1098_CR51","unstructured":"World Health Organization HIV Department: Prioritizing Second-Line Antiretroviral Drugs for Adults and Adolescents: A Public Health Approach, Report of a WHO Working Group Meeting. Geneva; 2007(May)."},{"key":"1098_CR52","volume-title":"Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities","author":"J Curran","year":"2005","unstructured":"Curran J, Debas H, Arya M, Knobler S, Pray L. Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities. Washington: The National Academies Press; 2005."},{"key":"1098_CR53","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1365-3156.2010.02655.x","volume":"15","author":"EJ Nelwan","year":"2010","unstructured":"Nelwan EJ, Van Crevel R, Alisjahbana B, Indrati AK, Dwiyana RF. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Trop Med Int Heal. 2010;15:1491\u20138.","journal-title":"Trop Med Int Heal"},{"key":"1098_CR54","volume-title":"Scaling up HIV\/AIDS care: service delivery & human resources perspectives","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Scaling up HIV\/AIDS care: service delivery & human resources perspectives. 2004."},{"issue":"2 Suppl","key":"1098_CR55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2004.71.147","volume":"71","author":"S Russell","year":"2004","unstructured":"Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus\/acquired immunodeficiency syndrome. Am J Trop Med Hyg. 2004;71(2 Suppl):147\u201355.","journal-title":"Am J Trop Med Hyg"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-1098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-015-1098-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-1098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T13:38:07Z","timestamp":1718113087000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-015-1098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1186\/s12913-015-1098-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"article-number":"440"}}